Cash & equivalents decreased 20.4%
Cash & equivalents changed -20.4% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -20.4% from the comparable as-filed period.
Inventory changed +575.3% from the comparable as-filed period.
Net income changed -48.1% from the comparable as-filed period.
Operating income changed -113.0% from the comparable as-filed period.
Operating margin changed -4462 basis points from the comparable as-filed period.
Research & development changed +1361.4% from the comparable as-filed period.
Selling, general & administrative changed +44.4% from the comparable as-filed period.
Stock-based compensation changed -67.4% from the comparable as-filed period.
Revenue changed +15.5% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.